Holding(s) in Company | 11-Apr-2024 | 11:44 | RNS |
Conversion Notice & Total Voting Rights | 05-Apr-2024 | 07:00 | RNS |
Half-year Report | 22-Mar-2024 | 07:00 | RNS |
Holding(s) in Company | 18-Mar-2024 | 11:36 | RNS |
New research project and CSO to return to academia | 18-Mar-2024 | 07:00 | RNS |
Conversion Notice and Total Voting Rights | 12-Mar-2024 | 07:00 | RNS |
Notice of Results | 08-Mar-2024 | 09:43 | RNS |
Conversion notice and alternative financing | 28-Feb-2024 | 12:41 | RNS |
Positive Interim AxisBiotix Acne study results | 27-Feb-2024 | 07:00 | RNS |
Dermatonics to launch Once Heel Balm in AMEA | 20-Feb-2024 | 07:00 | RNS |
Conversion Notice and Total Voting Rights | 09-Feb-2024 | 07:00 | RNS |
Dermatonics Full Year trading update | 06-Feb-2024 | 07:31 | RNS |
Completion of Acquisition of Dermatonics | 26-Jan-2024 | 07:00 | RNS |
Acquisition of Dermatonics | 25-Jan-2024 | 07:00 | RNS |
£5.0m Convertible Bond Facility & Fir... | 25-Jan-2024 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 9.20p |
Change Today | -0.050p |
% Change | -0.54 % |
52 Week High | 29.00 |
52 Week Low | 7.25 |
Volume | 236,233 |
Shares Issued | 200.38m |
Market Cap | £18.43m |
Beta | 0.01 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:18 | 70,000 @ 9.00p |
12:34 | 6,958 @ 9.00p |
12:34 | 15,000 @ 9.01p |
12:33 | 15,000 @ 9.06p |
12:31 | 25,000 @ 9.02p |
CEO | Stuart Ashman |
CFO | Manprit Singh Randhawa |
You are here: research